Osteoblast expression of an engineered Gs-coupled receptor dramatically increases bone mass

Area of Science:

• Bone Biology
• Endocrinology
• Skeletal Physiology

Background:

• Osteoblasts are crucial for bone mass maintenance, osteoporosis prevention, and bone repair.
• The anabolic mechanisms of osteoblast G protein-coupled receptors (GPCRs), like the parathyroid hormone receptor, remain incompletely understood.
• Understanding GPCR signaling in osteoblasts is key to developing treatments for metabolic bone diseases.

Purpose of the Study:

• To investigate the skeletal effects of constitutive G(s) signaling in murine osteoblasts using an engineered GPCR, Rs1.
• To evaluate the temporal sensitivity of osteoblasts to G(s) signaling.
• To explore the potential of G(s) signaling pathways for enhancing bone repair and treating bone diseases.

Main Methods:

• Utilized an engineered GPCR, Rs1, with constitutive G(s) signaling.
• Administered Rs1 expression in murine osteoblasts in vivo.
• Analyzed skeletal parameters including femur girth, mass, bone volume, cellularity, bone mineral density, osteoblast gene markers, and serum bone turnover markers.

Main Results:

• Rs1 expression induced a significant anabolic skeletal response in 9-week-old mice, with midfemur girth increasing 1,200% and femur mass increasing 380%.
• Elevated bone volume, cellularity, areal bone mineral density, osteoblast gene markers, and serum bone turnover markers were observed.
• No anabolic phenotype developed when Rs1 was expressed after the first 4 weeks of postnatal life, demonstrating temporal sensitivity.

Conclusions:

• Constitutive G(s) signaling via Rs1 in osteoblasts elicits a potent anabolic skeletal response.
• Osteoblast responsiveness to G(s) signaling is exquisitely sensitive to the timing of postnatal development.
• This pathway holds promise for future therapeutic strategies targeting bone repair and metabolic bone diseases.